Hubei Hongyuan Pharmaceutical Technology Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 301246?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	119,535	0.03%
Institutions	37,986,859	9.54%
General Public	122,353,606	30.7%
Individual Insiders	237,546,800	59.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 69.13% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
22.8%	Guoping Yin	90,552,000	CN¥1.3b	0%	no data
22.3%	Xiaohui Yan	88,585,200	CN¥1.3b	0%	no data
6.62%	Shuangxi Xu	26,346,600	CN¥383.9m	0%	no data
2.67%	Hubei Hongyuan Charity Foundation, Endowment Arm	10,628,800	CN¥154.9m	0%	no data
1.76%	Shanghai Daoji Investment Co., Ltd.	7,009,541	CN¥102.1m	0%	62.39%
1.74%	Xiaoliu Duan	6,915,400	CN¥100.8m	-7.98%	no data
1.52%	Yonghua Xiao	6,033,300	CN¥87.9m	0%	no data
1.51%	Gaoliang Lei	6,010,000	CN¥87.6m	-7.68%	no data
1.46%	Minsheng Equity Investment Fund Management Co., Ltd.	5,797,378	CN¥84.5m	0%	no data
1.44%	Zhanliang Liu	5,747,800	CN¥83.7m	0%	no data
1.14%	Zhihua Deng	4,544,000	CN¥66.2m	0%	no data
0.71%	Minsheng Securities Co., Ltd., Asset Management Arm	2,845,660	CN¥41.5m	0%	6.93%
0.63%	Siyuan Cheng	2,520,000	CN¥36.7m	0%	no data
0.63%	Changjiang Securities(shanghai)Asset Management Co.,Ltd.	2,504,927	CN¥36.5m	0%	0.86%
0.54%	Haitong Innovation Private Fund Management Co., Ltd.	2,135,682	CN¥31.1m	0%	7.0%
0.5%	Zhejiang Aobei Investment Management Co., Ltd.	2,006,100	CN¥29.2m	0%	100.0%
0.44%	China Southern Asset Management Co., Ltd.	1,753,209	CN¥25.5m	2,650%	0.01%
0.42%	Min Sheng Life Insurance Co., Ltd, Asset Management Arm	1,680,000	CN¥24.5m	0%	no data
0.1%	China Asset Management Co. Ltd.	412,800	CN¥6.0m	0%	no data
0.087%	GF Fund Management Co., Ltd.	348,238	CN¥5.1m	0%	no data
0.073%	Kefeng Zeng	292,500	CN¥4.3m	0%	no data
0.035%	CITIC Securities Company Limited, Asset Management Arm	138,711	CN¥2.0m	0%	no data
0.03%	Hubei Wanxing Construction Co., Ltd.	119,535	CN¥1.7m	0%	no data
0.029%	Western Leadbank Fund Management Co., Ltd.	113,700	CN¥1.7m	0%	0.01%
0.026%	Huatai Securities (Shanghai) Asset Management Co., Ltd.	103,917	CN¥1.5m	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:11
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hubei Hongyuan Pharmaceutical Technology Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution